Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Marker for Iron Availability Derived From Blood Test

By LabMedica International staff writers
Posted on 18 Jul 2011
Low hemoglobin density (LHD%) is a new parameter provided by an autoanalyzer that can be derived from the mean cell hemoglobin concentration. More...


The diagnosis of iron deficiency or functional iron deficiency is particularly challenging in patients with acute or chronic inflammatory conditions because most of the biochemical markers for iron metabolism are affected by acute phase reaction.

Scientists at the Hospital Galdakao – Usansolo, (Galdakao, Spain), used the program of the LH 780 analyzer to study 110 patients with iron deficiency (IDA); 65 with chronic kidney disease (CKD), and 85 with anemia of chronic disease (ACD), 24 of whom were iron deficient and 61 were iron sufficient and 90 healthy subjects. A total of 350 peripheral blood samples were analyzed during the 2-month period from March 2010 to April 2010.

Low hemoglobin density values showed no statistical difference in patients with IDA and patients with ACD accompanied with IDA. The LHD% values in these patients were significantly different compared with the iron-sufficient patients with ACD. Receiver operating characteristic (ROC) curve analysis for LHD% in the detection of iron deficiency showed the following: area under curve 0.903; cut off 5.5%, with a sensitivity of 88.6%, and a specificity of 76.9%.

The author concluded that in the present study the parameter, LHD% is useful for diagnosing iron deficiency and is a reliable parameter for recognizing subsets of anemic patients and therefore improving the diagnosis and management of anemia. The LHD% analysis can be performed simultaneously in the course of routine blood counts, with no incremental costs and no additional blood sampling. In conjunction with standard blood cell counts and iron parameters, LHD% could enable the diagnosis to be made rapid and accurately, when using the LH 780 analyzer (Beckman Coulter Inc., Miami, FL, USA). The study was published on July 4, 2011, in the International Journal of Laboratory Hematology.

Related Links:

Hospital Galdakao – Usansolo
Beckman Coulter Inc.



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.